Exploring the Interaction between Comorbid Psychiatric and Medical Diagnoses: The Potential Impact of Borderline Personality Disorder on Adherence to Highly Active Antiretroviral Therapy (HAART)
Restricted accessResearch articleFirst published online November, 2006
Exploring the Interaction between Comorbid Psychiatric and Medical Diagnoses: The Potential Impact of Borderline Personality Disorder on Adherence to Highly Active Antiretroviral Therapy (HAART)
It is well documented that patient adherence to medical advice and prescription medication is suboptimal. While the reasons for non-compliance are varied and complex, it is essential that they be expounded to facilitate the efficacy of medical interventions. In no other illness is this more pertinent than with the human immunodeficiency virus (HIV). Highly active antiretroviral therapy (HAART) has become the first line of treatment for HIV, but stringent adherence is a prerequisite for therapeutic efficacy. As with other treatments, adherence to HAART is problematic. One factor that may play a significant role is if the patient has a comorbid psychiatric illness. This article provides a theoretical exposition of how a patient with Borderline Personality Disorder (BPD) might suffer innumerable exigencies with adherence as a hypothesised function of the individual properties of his or her illness that is likely to be compounded when the properties interact with one another.
AlbusC.SchmeißerN.SalzbergerB.FätkenuerG. (2005). Preferences regarding medical and psychosocial support in HIV-infected patients. Patient Education and Counselling, 56(1), 16–20
2.
American Psychiatric Association (APA). (2000a). Diagnostic and statistical manual of mental disorders: Text revision (DSM-IV-TR) (4th ed.). Washington, DC: APA
3.
American Psychiatric Association (APA). (2000b). Quick reference to the diagnostic criteria from DSM-IV-TR.Washington, DC: APA
4.
AngelinoA. F.TreismanG. J. (2001). Management of psychiatric disorders in patients infected with human immunodeficiency virus. HIV/AIDS, 33, 847–855
5.
ArntzA. (2005). Introduction to special issue: Cognition and emotion in borderline personality disorder. Journal of Behaviour Therapy and Experimental Psychiatry, 36, 167–172
ChesneyM. A.MorinM.SherrL. (2000). Adherence to HIV combination therapy. Social Science and Medicine, 50(11), 1599–1603
11.
del RioC. (2005). AIDS: The second wave. Archives of Medical Research, 36(6), 682–688
12.
EkstrandM. L.ChesneyM. A. (2002). Adhering to complex medication regimens. In ChesneyM. A.AntoniM. H. (Eds.), Innovative approaches to health psychology: Prevention and treatment lessons from AIDS (pp. 283–306). Washington, DC: American Psychological Association
13.
EleyB. (In press). Addressing the paediatric HIV epidemic: A perspective from the Western Cape Region of South Africa.Transactions of the Royal Society of Tropical Medicine and Hygiene.
14.
FerradiniL.JeanninA.PinogesL.IzopetJ.OdhiamboD.MankhamboL.KarungiG.SzumilinE.BalandineS.FedidaG.CarriedM. P.SpireB.FordN.TassieJ-M.GuerinP. J.BrasherC. (2006). Scaling up of highly active antiretroviral therapy in a rural district of Malawi: An effectiveness assessment. The Lancet, 367(9519), 1335–1342
15.
FogartyL.RoterD.LarsonS.BurkeJ.GillespieJ.LevyR. (2002). Patients' adherence to HIV medication regimens: A review of published and abstract reports. Patients Education and Counselling, 46(2), 93–108
16.
HagiwaraE.KatsuseO.OkubuT.ShiraiA.ItohA.IshigatsuboY. (2000). Two cases of HIV infection accompanied with borderline personality disorder. The Journal of the Japanese Association for Infectious Diseases, 74(12), 1077–1080
17.
HalmanM. H.BialerP.WorthJ. L.RourkeS. B. (2002). HIV disease/AIDS. In WiseM. G.RundellJ. R. (Eds.), Textbook of consultation-liaison psychiatry: Psychiatry in the medically ill (pp. 807–852). Washington, DC: American Psychiatric Press
18.
HamiltonN. G. (1990). Self and others: Object Relations Theory in practice.Northvale, NJ: Aronson
19.
Harvard mental health letter. (2002). Borderline personality: New recommendations. 18(9).New Haven, CT: Yale University Press
20.
HerpertzS. C. (2003). Emotional processing in personality disorder. Current Psychiatry Reports, 5(1), 23–27
21.
HIV/AIDS treatment adherence, health outcomes and cost study group. (2004). The HIV/AIDS treatment adherence, health outcomes and cost study: Conceptual foundations and overview. AIDS Care, 16(Supplement 1), S6–S21
22.
HoustonR. J.CeballosN. A.HesselbrockV. M.O'BauerL. (2005). Borderline personality disorder features in adolescent girls: P300 evidence of altered brain maturation. Clinical Neuropsychology, 116(6), 1424–1432
23.
HymanS. E. (2002). A new beginning for research on borderline personality disorder. Biological Psychiatry, 51(12), 933–935
24.
IckovicksJ. R.MeadeC. S. (2002). Adherence to HAART among patients with HIV: Breakthroughs and barriers. AIDS Care, 14(3), 309–318
25.
RobertsJohnston K.MannT. (2000). Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care, 12(4), 377–386
26.
KaraszA.DycheL.SelwynP. (2003). Physicians' experiences of caring for late-stage HIV patients in the post-HAART era: Challenges and adaptations. Social Science and Medicine, 57(9), 1609–1620
27.
KernbergO. F. (1967). Borderline personality organization. Journal of the American Psychoanalytic Association, 15, 641–685
28.
KlugerJ.SongS. (2003). Masters of denial. Time, 161(3), 84–86
LinehanM. M.ArmstrongH. E.SuarezA.AllmonD.HeardH. L. (1991). Cognitive-behavioural treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48, 1060–1064
31.
MeelB. L. (2005). Ethical issues related to HIV/AIDS: Case reports. Journal of Clinical Forensic Medicine, 12(3), 149–152
32.
MohanR. (2002). Treatments for borderline personality disorder: Integrating evidence into practice. International Review of Psychiatry, 14, 42–51
33.
MugaveroM.HicksC. (2004). HIV resistance and the effectiveness of combination antiretroviral treatment. Drug Discovery Today: Therapeutic Strategies, 1(4), 529–535
34.
NairM.LayS. (2001). Personality disorders. In RobertsonB.AllwoodC.GagianoC. (Eds.), Textbook of psychiatry for Southern Africa (pp. 249–264). Cape Town: Oxford University Press
35.
OhshimaT. (2001). Borderline personality traits in hysterical neurosis. Psychiatry and Clinical Neurosciences, 55, 131–136
36.
OpieL. H. (2005). HIV/AIDS in South Africa. The Lancet, 366(9482), 291
37.
PenedoF.GonzalezJ.DahnJ.AntoniM.MalowR.CostaP.SchneidermanN. (2003). Personality, quality of life and HAART adherence among men and women living with HIV/AIDS. Journal of Psychosomatic Research, 54(3), 271–278
38.
RemienR. H.RabkinJ. G. (2002). Managing chronic disease: Individual counselling with medically ill patients. In ChesneyM. A.AntoniM. H. (Eds.), Innovative approaches to health psychology: Prevention and treatment lessons from AIDS (pp. 117–139). Washington, DC: American Psychological Association
39.
RennebergB.HeynK.GebhardR.BachmannS. (2005). Facial expression of emotions in borderline personality disorder and depression. Journal of Behaviour Therapy and Experimental Psychiatry, 36(3), 183–196
40.
ReynoldsN. R. (2003). The problem of antiretroviral adherence: A self-regulatory model for intervention. AIDS Care, 15(1), 117–124
41.
RicartF.CohenM.AlfonsoC.HoffmanR.QuiñonesN.CohenA.IndykD. (2002). Understanding the psychodynamics of non-adherence to medical treatment in persons with HIV infection. General Hospital Psychiatry, 24(3), 176–180
42.
RosenthalM. Z.CheavensJ. S.LejuezC. W.LynchT. R. (2004). Thought suppression mediates the relationship between negative affect and borderline personality disorder symptoms. Behaviour Research and Therapy, 43(9), 1173–1185
43.
SafrenS. A.OttoM. W.WorthJ. L.SalomonE.JohnsonW.MayerK.BoswellS. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life-steps and medication monitoring. Behaviour Research and Therapy, 39(10), 1151–1162
44.
SherrL. (2000). Adherence: Sticking to the evidence. AIDS Care, 12(4), 373–375
45.
SkodolA. E.GundersonJ. G.PfohlB.WidigerT. A.LivesleyW. J.SieverL. J. (2002). The borderline diagnosis I: Psychopathology, comorbidity, and personality structure. Biological Psychiatry, 51(12), 936–950
46.
SperryL. (1995). Handbook of diagnosis and treatment of the DSM-IV personality disorders.New York: Brunner/Mazel
47.
SpireB.DuranS.SouvilleM.LeportC.RaffiF.MoattiJ. (2002). Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive to a dynamic approach. Social Science and Medicine, 54(10), 1481–1496
48.
StilleyC. S.DewM. A.PilkonisP.BenderA.McNultyM.ChristensenA.McCurryK. R.KormosR. L. (2005). Personality characteristics among cardiothoracic transplant recipients. General Hospital Psychiatry, 27(2), 113–118
49.
TangJ.PillayD. (2004). Transmission of HIV-1 drug resistance. Journal of Clinical Virology, 30(1), 1–10
50.
The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration and ART Cohort Collaboration (ART-CC) groups (2006). Mortality of HIV-1 infected patients in the first years of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet, 367, 817–824
51.
TseT. (2001). Review of R. Krawitz & C. Watson, Borderline personality disorder: Foundations for treatment. Australian and New Zealand Journal of Mental Health Nursing, 10, 61
52.
UldallK. K.PalmerN. B.WhettenK.MellinsC. (2004). Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: A review of the literature. AIDS Care, 16(Supplement 1), S71–S96
53.
UrsanoR. J.EpsteinR. S.LazarS. G. (2002). Behavioural response to illness. In WiseM. G.RundellJ. R. (Eds.), Textbook of consultation-liaison psychiatry: Psychiatry in the medically ill (pp. 107–126). Washington, DC: American Psychiatric Press
54.
van der BorghtS.de WitT. F. R.JanssensV.van der LoeffM. F. S.RijckborstH.LangeJ. M. A. (2006). HAART for the HIV-infected employees of large companies in Africa. The Lancet, 368(9533), 547–550
55.
VieiraA.RebochoL.SousaA.AzevedoF. (2003). HIV infection and adherence to therapy during HIV disease. European Journal of Internal Medicine, 14, S114
56.
WalshJ. C.HorneR.DaltonM.BurgessA. P.GazzardB. G. (2001). Reasons for non-adherence to antiretroviral therapy: Patients' perspectives provide evidence for multiple causes. AIDS Care, 13(6), 703–720
57.
WareN.WyattM.TugenbergT. (2005). Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs. Social Science and Medicine, 61(3), 565–576
58.
Wirth-CauchonJ. (2001). Women and borderline personality disorder: Symptoms and stories.New Brunswick, NJ: Rutgers University Press
59.
World Health Organisation (WHO). (2003). Adherence to long-term therapies: Evidence in action.Geneva: WHO
60.
WrightM. T. (2000). The old problem of adherence: Research on treatment adherence and its relevance for HIV/AIDS. AIDS Care, 12(6), 703–710
61.
YatesW. R. (2002). Epidemiology of psychiatric disorders in medically ill patients. In WiseM. G.RundellJ. R. (Eds.), Textbook of consultation-liaison psychiatry: Psychiatry in the medically ill (pp. 237–256). Washington, DC: American Psychiatric Press
